Porinju Veliyath made a name for himself during the smallcap and midcap boom of 2016-2018.
MUMBAI: The dream run in the domestic midcap and smallcap stocks over the past 12 months would have led keen observers of India’s stock market to assume that Porinju Veliyath, one of the country’s most eccentric value investors, will make a major comeback in the investment scene.
Since hitting their multi-year lows in March 2020, midcap and smallcap stocks have made a roaring comeback, as is reflected in the over 100 per cent gains in the Nifty Midcap 100 and Nifty Smallcap 100 indices for the past 12 months.
In the same period, Veliyath has seen the asset under management of his PMS more than double to Rs 1,182 crore, latest data available on the Sebi website showed.
The stellar returns in his portfolio, however, were not enough to win back clients that the fund lost during its lean year. Equity Intelligence lost another 224 clients in the financial year ended March 2021, after 236 clients exited the fund in 2019-20, data on the Sebi website showed.
Veliyath made a name for himself during the smallcap and midcap boom of 2016-2018, as asset under management of his portfolio management service quadrupled to Rs 1,574 crore and the client base almost tripled.
<iframe title="Porinju Veliyath's PMS Returns and AuM Performance" aria-label="Interactive line chart" id="datawrapper-chart-ZGzPV" src="https://datawrapper.dwcdn.net/ZGzPV/1/" scrolling="no" frameborder="0" style="width: 0; min-width: 100% !important; border: none;" height="400"></iframe><script type="text/javascript">!function(){"use strict";window.addEventListener("message",(function(a){if(void 0!==a.data["datawrapper-height"])for(var e in a.data["datawrapper-height"]){var t=document.getElementById("datawrapper-chart-"+e)||document.querySelector("iframe[src*='"+e+"']");t&&(t.style.height=a.data["datawrapper-height"][e]+"px")}}))}();
ADVERTISEMENT
</script> Yet, the subsequent two years were ‘humbling’ in the fund manager’s own words. “The last selloff was indeed a humbling one, and I believe I have emerged out of it a bit wiser. My optimism about promoters turning around and systems changing has certainly sobered down,” Veliyath told ETMarkets.com in his first-ever interview following a self-imposed media blackout over the past few years.
In the bear market in midcap and smallcap stocks that started in early 2018, Veliyath’s portfolio management service saw its assets under management decline nearly 75 per cent, while he also lost some of his clients.
Investors in Veliyath’s PMS did not ditch his investment style the moment the returns started to dwindle. In fact, when the PMS’ asset under management tanked 25 per cent in 2018-19, the fund added nearly 270 new clients.
At that time, Veliyath accepted the sharp drop in his fund’s performance, but continued to predict that the initial fall in midcap and smallcap stocks was the right time to plunge in.
ADVERTISEMENT
“After this big fall, I think this is the most exciting time when I look back in the last five years. Now is the time to really look at and load up on select midcaps and smallcaps,” Veliyath told CNBC-TV18 in an interview in mid-2018.
7 stocks analysts recommend for handsome near-term returns
1/8
Which stocks to buy now? Wild swings in the market at the onset of the earnings season and the reimposition of lockdowns to curb the Covid-19 pandemic have left many investors wondering whether there are any untapped opportunities to make money on Dalal Street.
Here are seven technical picks that analysts believe can help traders make good gains in the coming weeks:
Which stocks to buy now? Wild swings in the market at the onset of the earnings season and the reimposition of lockdowns to curb the Covid-19 pandemic have left many investors wondering whether there..
Read More
Cipla has gained momentum after breaking out from an all-time high, with momentum indicators MACD and RSI indicating further upside. A 'buy' is recommended on 'Cipla' above Rs 905 for a target of Rs 995, with a stop loss at Rs 790.
(Analyst: Ashis Biswas, Head of Technical Research, CapitalVia Global Research)
Cipla has gained momentum after breaking out from an all-time high, with momentum indicators MACD and RSI indicating further upside. A 'buy' is recommended on 'Cipla' above Rs 905 for a target of Rs ..
Read More
An upmove in the stock near the support of Rs 275 after the formation of a positive candlestick pattern hints at a crucial bottom reversal at the lows. A further rise is likely to confirm this pattern. Buying at the current price and adding on dips towards Rs 280 is recommended on the stock for a target of Rs 320 in the coming 3-4 weeks, with a stop loss at Rs 272.
(Analyst: Nagaraj Shetti, Technical Research Analyst, HDFC Securities)
An upmove in the stock near the support of Rs 275 after the formation of a positive candlestick pattern hints at a crucial bottom reversal at the lows. A further rise is likely to confirm this patter..
Read More
A correction in the stock appears to be ending in the stock around Rs 98-100 levels on the weekly chart, with the weekly 14-period Relative Strength Index looking positive. Buying can be initiated at the current levels, and dips towards Rs 98 can be used to add, for a target of Rs 113 in the next 3-4 weeks with a stop loss at Rs 95.
(Analyst: Nagaraj Shetti, Technical Research Analyst, HDFC Securities)
A correction in the stock appears to be ending in the stock around Rs 98-100 levels on the weekly chart, with the weekly 14-period Relative Strength Index looking positive. Buying can be initiated at..
Read More
The stock appears to be in a strong upmove, with a long green candle that closed at a day's high confirming the bullish outlook. Overall depression in the market has not dampened the rally in Oriental Aromatics with moving averages showing a good crossover effect as a bullish sign. The stock can be bought at the current levels from a 3-4 week view for a target of Rs 800 and then Rs 850, with a stop below Rs 640.
(Analyst: Manish Shah, Trader, Researcher and Trading Coach, Niftytriggers.com)
The stock appears to be in a strong upmove, with a long green candle that closed at a day's high confirming the bullish outlook. Overall depression in the market has not dampened the rally in Orienta..
Read More
The stock has support at its 55-day exponential moving average, indicating a positive outlook, with momentum indicators MACD and RSI also hinting at continuation of momentum. Investors may take a long position from a medium-term perspective for a target of Rs 2,450 with a stop loss at Rs 1,920.
(Analyst: Ashis Biswas, Head of Technical Research, CapitalVia Global Research)
The stock has support at its 55-day exponential moving average, indicating a positive outlook, with momentum indicators MACD and RSI also hinting at continuation of momentum. Investors may take a lon..
Read More
The stock has been trading above its 200-day moving average, hinting at continuation of a positive momentum. Investors can look at buying Graphite for a target of Rs 790 in the medium term with a stop loss at Rs 440.
(Analyst: Ashis Biswas, Head of Technical Research, CapitalVia Global Research)
The stock has been trading above its 200-day moving average, hinting at continuation of a positive momentum. Investors can look at buying Graphite for a target of Rs 790 in the medium term with a sto..
Read More
The stock appears to be moving in a range on the weekly chart with the possibility of a rectangle pattern. The magnitude of this range looks fairly wide, which indicates a good-risk reward ratio if the price rallies to Rs 1,200 over the next couple of weeks. Alembic Pharma has confirmed a breakout from a double bottom pattern and a rally is expected till Rs 1,100, and then Rs 1,180. A long position can be held for 3-4 weeks with a stop below Rs 890.
(Analyst: Manish Shah, Trader, Researcher and Trading Coach, Niftytriggers.com)
The stock appears to be moving in a range on the weekly chart with the possibility of a rectangle pattern. The magnitude of this range looks fairly wide, which indicates a good-risk reward ratio if t..
That prediction fell flat as midcap and smallcap stocks continued to plumb lower in the next year before it culminated in the capitulation in the Covid-led crash of March 2020.
ADVERTISEMENT
Despite the adversity faced over the past three years, Veliyath has not lost his sense of optimism for the Indian economy or the broad market. In his February interview to ETMarkets.com, the maverick value investor blew the bugle on India’s growth trajectory and return potential of value investing.
Veliyath will hope the performance of his PMS over the past 12 months is a lead indicator for a possible return of the good times going forward.